These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 16329176

  • 1. AIDS vaccine test to be expanded based on upbeat results.
    AIDS Read; 2005 Nov; 15(11):561, 573. PubMed ID: 16329176
    [No Abstract] [Full Text] [Related]

  • 2. Outwitting HIV: Minnesota researchers take on a clever virus.
    Bell H.
    Minn Med; 2009 Oct; 92(10):22-6. PubMed ID: 19916268
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HIV vaccine efficacy trials: towards the future of HIV prevention.
    Kim D, Elizaga M, Duerr A.
    Infect Dis Clin North Am; 2007 Mar; 21(1):201-17, x. PubMed ID: 17502236
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chimeric adenovirus 5/35 vector containing the clade C HIV gag gene induces a cross-reactive immune response against HIV.
    Xin KQ, Sekimoto Y, Takahashi T, Mizuguchi H, Ichino M, Yoshida A, Okuda K.
    Vaccine; 2007 May 10; 25(19):3809-15. PubMed ID: 17386962
    [Abstract] [Full Text] [Related]

  • 10. HIV-1 T-cell vaccines: evaluating the next step.
    Pantaleo G.
    Lancet Infect Dis; 2008 Feb 10; 8(2):82-3. PubMed ID: 18060842
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Support for the RV144 HIV vaccine trial.
    Belshe R, Franchini G, Girard MP, Gotch F, Kaleebu P, Marthas ML, McChesney MB, McCullough R, Mhalu F, Salmon-Ceron D, Sekaly RP, van Rompay K, Verrier B, Wahren B, Weissenbacher M.
    Science; 2004 Jul 09; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Building on the past to define an efficient path to an HIV vaccine.
    Korber B.
    Expert Rev Vaccines; 2011 Jul 09; 10(7):929-31. PubMed ID: 21806390
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.
    Heeney JL, Hahn BH.
    AIDS; 2000 Jul 09; 14 Suppl 3():S125-7. PubMed ID: 11086855
    [No Abstract] [Full Text] [Related]

  • 19. Why we don't need a relative risk standard for adolescent HIV vaccine trials in South Africa.
    Slack CM.
    Am J Bioeth; 2011 Jun 09; 11(6):21-2. PubMed ID: 21678209
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.